These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 30122153

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Time- and Dose-Dependent Effects of Hyaluronidase on the Degradation of Different Hyaluronan-Based Fillers In Vitro.
    Gerber PA, Buhren BA, Bölke E, Philipp-Dormston WG, Homey B, Schrumpf H.
    Plast Reconstr Surg; 2023 Mar 01; 151(3):560-567. PubMed ID: 36730370
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.
    Juhász MLW, Levin MK, Marmur ES.
    Dermatol Surg; 2017 Jun 01; 43(6):841-847. PubMed ID: 28498207
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.
    Ryu C, Lu JE, Zhang-Nunes S.
    J Plast Reconstr Aesthet Surg; 2021 Apr 01; 74(4):881-889. PubMed ID: 33308988
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resolve and dissolve-An ultrasound-guided investigation on the effects of hyaluronidase on different soft tissue fillers.
    Bravo BSF, Cavalcante T, Silveira C, Bravo LG, Zafra MC, Elias MC.
    J Cosmet Dermatol; 2024 Oct 01; 23(10):3173-3181. PubMed ID: 38769647
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multidose Hyaluronidase Administration as an Optimal Procedure to Degrade Resilient Hyaluronic Acid Soft Tissue Fillers.
    Flégeau K, Jing J, Brusini R, Gallet M, Moreno C, Walker L, Bourdon F, Faivre J.
    Molecules; 2023 Jan 19; 28(3):. PubMed ID: 36770671
    [Abstract] [Full Text] [Related]

  • 15. The Myth of the "Biphasic" Hyaluronic Acid Filler.
    Öhrlund JÅ, Edsman KL.
    Dermatol Surg; 2015 Dec 19; 41 Suppl 1():S358-64. PubMed ID: 26618465
    [Abstract] [Full Text] [Related]

  • 16. Hyaluronidase Caveats in Treating Filler Complications.
    Landau M.
    Dermatol Surg; 2015 Dec 19; 41 Suppl 1():S347-53. PubMed ID: 26618463
    [Abstract] [Full Text] [Related]

  • 17. The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.
    Kim HJ, Kwon SB, Whang KU, Lee JS, Park YL, Lee SY.
    J Cosmet Laser Ther; 2018 Feb 19; 20(1):52-57. PubMed ID: 29199877
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fundamental considerations for the use of hyaluronidase, an enzyme for degrading HA fillers.
    Hong GW, Yi KH.
    Skin Res Technol; 2024 Jul 19; 30(7):e13839. PubMed ID: 38951943
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.